Evidence map›Paper›PMID 28852070›Full record

ArticleScientific reports2017

Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity.

Cho-Rong Bae, Jun Hino, Hiroshi Hosoda, Yuji Arai, Cheol Son, Hisashi Makino, Takeshi Tokudome, Tsutomu Tomita, Toru Kimura, Takashi Nojiri and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Cho-Rong BaeDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Jun HinoDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan. jhino@ncvc.go.jp.
Hiroshi HosodaDepartment of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Yuji AraiDepartment of Bioscience and Genetics, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Cheol SonDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hisashi MakinoDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Takeshi TokudomeDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Tsutomu TomitaDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Toru KimuraDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Takashi NojiriDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Kiminori HosodaDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Mikiya MiyazatoDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Kenji KangawaDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan. kangawa@ri.ncvc.go.jp.
National Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endogenous peptide C-type natriuretic peptide (CNP) binds its receptor, guanylyl cyclase B (GCB), and is expressed by endothelial cells in diverse tissues. Because the endothelial cells of visceral adipose tissue have recently been reported to play a role in lipid metabolism and inflammation, we investigated the effects of CNP on features of obesity by using transgenic (Tg) mice in which CNP was placed under the control of the Tie2 promoter and was thus overexpressed in endothelial cells (E-CNP). Here we show that increased brown adipose tissue thermogenesis in E-CNP Tg mice increased energy expenditure, decreased mesenteric white adipose tissue (MesWAT) fat weight and adipocyte hypertrophy, and prevented the development of fatty liver. Furthermore, CNP overexpression improved glucose tolerance, decreased insulin resistance, and inhibited macrophage infiltration in MesWAT, thus suppressing pro-inflammation during high-fat diet-induced obesity. Our findings indicate an important role for the CNP produced by the endothelial cells in the regulation of MesWAT hypertrophy, insulin resistance, and inflammation during high-fat diet-induced obesity.

Indexed as

Diet, High-FatGene ExpressionAdipocytesAnimalsEndothelial CellsEnergy MetabolismGlucose IntoleranceGuanylate CyclaseInflammationInsulin ResistanceLiverMiceMice, TransgenicNatriuretic Peptide, C-TypeObesityRNA, MessengerGuanylate CyclaseNatriuretic Peptide, C-TypeRNA, Messenger

Identifiers

PMID28852070
PMCPMC5574992
OpenAlexW2747631389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.